WIRE — The deal must be accepted by 95% of the ovarian cancer claimants in state or federal court before it becomes final
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.